Abstract:Aims: Serum- and glucocorticoid-inducible kinase 1 (SGK1) protects neuronal cells from injury stimuli in vitro, and exerts anti-apoptotic effects via downstream targets including the forkhead-like transcription factor FOXO3a. SGK1 is a homolog of Akt, a related survival kinase that is up-regulated in Alzheimer's disease (AD). Here we aimed to examine the expression pattern of SGK1 and FOXO3a in aged human cerebral cortex. Methods: Cortical tissue from aged donors without brain disease (aged controls, AC, n = 19) and from severe AD patients (Braak stage V-VI; n = 14) were examined by immunohistochemistry and immunoblot analysis. Results: SGK1 was present in all samples (detected by immunohistochemistry and immunoblotting). Large cortical neuronal cells were strongly positive for SGK1, with predominantly nuclear labelling. Some astrocytes and oligodendrocytes were also labelled. SGK1 was not seen in nerve tracts (axons or myelin) and rarely seen in CD68-positive cells (microglia, perivascular macrophages) or vascular cells (myocytes or endothelia). The fraction of large cortical neurones with nuclear FOXO3a was lower in AD cases relative to AC (54%, 70%, respectively, P < 0.001). In immunoblots no difference in SGK1 abundance was detected between AC and AD tissues. Phosphorylation of NDRG1 (an SGK1-specific target) was greater in AD, relative to AC cases (approximately twofold, P = 0.023). Conclusions: Neuronal expression of SGK1 in aged human brain and its nuclear compartmentalization suggest a possible neuroprotective role. FOXO3a and NDRG1 data suggest augmented SGK1 activity (as reported for Akt) in severe AD. Increased intracellular SGK1 may complement enhanced Akt, with a distinct subcellular localization.

The role of serum-glucocorticoid regulated kinase 1 in reproductive viability: implications from prenatal programming and senescence

Involvement Of Serum Glucocorticoid-Regulated Kinase 1 In Reproductive Success

Role of Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) in Immune and Inflammatory Diseases

SGK1 and Metabolic Syndrome

SGK1 in Human Cancer: Emerging Roles and Mechanisms

Apurinic/apyrimidinic Endodeoxyribonuclease 1 (APE1) Promotes Stress Granule Formation Via YBX1 Phosphorylation in Ovarian Cancer

Serum- and glucocorticoid-inducible kinase 1 promotes insulin resistance in adipocytes via degradation of insulin receptor substrate 1

Serum and Glucocorticoid Regulated Kinase 1 in Sodium Homeostasis

SATB1, senescence and senescence‐related diseases

Serum/glucocorticoid regulated kinase 1 (SGK1) in neurological disorders: pain or gain

The role of serum/glucocorticoid-regulated kinase 1 in brain function following cerebral ischemia

The long-term negative effects of early life stress on SGK1 modulation: the key role of epigenetic mechanisms

Role of KSP1 in replicative lifespan regulation of Saccharomycds cdrdvisiad

Cellular senescence: the good, the bad and the unknown

The cell survival kinase SGK1 and its targets FOXO3a and NDRG1 in aged human brain

c-Jun N-terminal kinase signaling in cellular senescence

Implication of cellular senescence in the progression of chronic kidney disease and the treatment potencies

To target cellular senescence in diabetic kidney disease: the known and the unknown

Renal Programming by Transient Postnatal Overfeeding: The Role of Senescence Pathways

Serum and glucocorticoid-regulated kinase 1 (SGK1) as an emerging therapeutic target for cardiac diseases

A large-scale CRISPR screen and identification of essential genes in cellular senescence bypass.